GRCE
Grace Therapeutics Inc.
$3.58
+$0.25(+7.51%)
83
Overall
--
Value
83
Tech
--
Quality
Market Cap
$44.68M
Volume
759.95K
52W Range
$1.75 - $5.18
Target Price
$8.97
Key Metrics Overview
| Market Cap | $44.68M | P/E Ratio | N/A |
| 52W High | $5.18 | 52W Low | $1.75 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -43.0% | 52W Position | 53.4% |
| Overall Score | 83 | Value Score | -- |
| Quality Score | -- | Technical Score | 83 |
Growth Analysis
| EPS Current Est | $-1.11 | EPS Next Est | $-0.75 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRCE | $3.58 | +7.5% | 759.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |